Brian Varnum
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Brian Varnum
Earlier roles on record: CEO and Board Member at Armata Pharmaceuticals, Inc. (ARMP) until July 10, 2023. Armata Pharmaceuticals, Inc. reported in an 8-K filed July 19, 2023 that Brian Varnum resigned as member of the Company's board of directors, effective July 10, 2023. Armata Pharmaceuticals, Inc. reported in an 8-K filed July 19, 2023 that Brian Varnum was terminated as Chief Executive Officer, effective July 10, 2023. Armata Pharmaceuticals, Inc. reported in an 8-K filed July 11, 2023 that Brian Varnum resigned as Board, effective July 10, 2023. Equibles holds 4 filed executive changes naming Brian Varnum; each is listed under recent activity with its source filing. The proxy statement of Armata Pharmaceuticals, Inc. reports total compensation of $634,140 for Brian Varnum in fiscal 2023, including a base salary of $331,002. Disclosed compensation is on record for 6 fiscal years.
“You hereby confirm your resignations from all offices, directorships, trusteeships, committee memberships and fiduciary and other capacities held with, or on behalf of, the Company Group (including, without limitation, as a member of the Company's board of directors) effective as of the Separation Date”
“On July 14, 2023, Armata Pharmaceuticals, Inc. (the "Company") and Dr. Brian Varnum, the Company's former Chief Executive Officer, entered into a separation and release agreement (the "Separation Agreement"). Pursuant to the Separation Agreement, Dr. Varnum is entitled to (i) continued payment of his base salary for twelve (12) months following the date on which his employment with the Company terminated (which occurred on July 10, 2023) (the "Separation Date")”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Armata Pharmaceuticals, Inc. (ARMP)
Proxy statement
Start not stated–2021-04-21
Last confirmed by a filing; no departure on record
-
Start not stated–2023-07-10
-
Start not stated–2023-07-10
-
Start not stated–2023-07-10
-
Start not stated–2023-07-10
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Armata Pharmaceuticals, Inc. (ARMP) | Former Chief Executive Officer | $331,002 | $634,140 |
| 2022 | Armata Pharmaceuticals, Inc. (ARMP) | Former Chief Executive Officer | $525,000 | $1,639,908 |
| 2021 | Armata Pharmaceuticals, Inc. (ARMP) | Ph. D. Chief Executive Officer | $463,688 | $1,475,935 |
| 2020 | Armata Pharmaceuticals, Inc. (ARMP) | Chief Executive Officer (former President and Chief Development Officer) | $398,750 | $611,754 |
| 2019 | Armata Pharmaceuticals, Inc. (ARMP) | Ph. D. President and Chief Development Officer | $320,000 | $1,124,156 |
| 2018 | Armata Pharmaceuticals, Inc. (ARMP) | Ph. D. President and Chief Development Officer | $320,000 | $448,000 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.